Keitaro Omori Selected Research

Keitaro Omori Research Topics

2	COVID-19 07/2022 - 01/2022
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2019 - 01/2016
2	Neoplasms (Cancer) 01/2016 - 01/2009
2	Atopic Dermatitis (Atopic Eczema) 12/2002 - 09/2002
1	Ureterocele 10/2022
1	Pyelonephritis 10/2022
1	Nocardia Infections 07/2022
1	Brain Abscess (Abscess, Brain) 07/2022
1	Exanthema (Rash) 04/2022
1	Injection Site Reaction 04/2022
1	Arthralgia (Joint Pain) 04/2022
1	Fatigue 04/2022
1	Nausea 04/2022
1	Fever (Fevers) 04/2022
1	Headache (Headaches) 04/2022
1	Suppuration 02/2022
1	Lung Neoplasms (Lung Cancer) 02/2022
1	Bacteremia 11/2021
1	Intraabdominal Infections 08/2021
1	Hydronephrosis 02/2021
1	Hyperplasia 02/2021
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 02/2021
1	Diabetes Mellitus 02/2021
1	Tuberculosis (Tuberculoses) 01/2020
1	Latent Tuberculosis 01/2020
1	Polycythemia Vera 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Fibrosis (Cirrhosis) 10/2019
1	Malignant Mesothelioma 01/2016
1	Respiratory Insufficiency (Respiratory Failure) 08/2009
1	Hearing Loss (Hearing Impairment) 08/2009
1	Hemorrhage 08/2009
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 06/2009
1	Infections 06/2009
1	Thrombosis (Thrombus) 01/2009
1	Carcinoma (Carcinomatosis) 01/2009
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2009
1	Pulmonary Embolism 01/2009

2	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 02/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019 - 01/2016
2	SK-216IBA 01/2016 - 01/2016
2	Plasminogen Activator Inhibitor 1IBA 01/2016 - 01/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2016 - 01/2016
1	Sulfamethoxazole FDA LinkGeneric 07/2022
1	Trimethoprim (Proloprim)FDA LinkGeneric 07/2022
1	casirivimab and imdevimab drug combinationIBA 07/2022
1	2019-nCoV Vaccine mRNA-1273IBA 04/2022
1	VaccinesIBA 04/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Prednisolone (Predate)FDA LinkGeneric 02/2022
1	Anti-Infective Agents (Microbicides)IBA 08/2021
1	SteroidsIBA 02/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Serum AlbuminIBA 02/2021
1	ruxolitinibIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2009
1	Rheumatoid FactorIBA 06/2009
1	Therapeutic UsesIBA 06/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009
1	AnticoagulantsIBA 01/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	Complementary DNA (cDNA)IBA 12/2002
1	Chemokine CCL17IBA 09/2002
1	CytokinesIBA 09/2002
1	Messenger RNA (mRNA)IBA 09/2002
1	ChemokinesIBA 09/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002
1	Interleukin-4 (Interleukin 4)IBA 09/2002

4	Therapeutics 07/2022 - 01/2009
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 08/2009
1	Stents 10/2022
1	Nephrotomy 10/2022
1	Lung Transplantation 07/2022
1	Spinal Fusion (Spondylosyndesis) 02/2022
1	Lasers (Laser) 11/2021
1	Plasmapheresis 08/2009
1	Remission Induction 06/2009
1	Thrombolytic Therapy 01/2009
1	Drug Therapy (Chemotherapy) 01/2009